个人简介：

Jeff He is the Co-Founder & CEO at TandemAI. He brings 20+ year leadership experience in corporate strategy, business development, venture financing and operation.

Previously, Jeff co-founded HiFiBiO Therapeutics and served as its Chief Operating Officer since 2017. Prior to that, Jeff was co-founder & CFO at Harbour BioMed from 2015 to 2017. Before launching his entrepreneurial career, Jeff served as Executive Vice President of Strategy and Operation at ShangPharma/ChemPartner for 3 years. Mr. He also served as Senior Vice President at Texas Pacific Group (TPG), where he helped to privatize ShangPharma from the NYSE. Prior to TPG, Mr. He held management roles with increasing P&L responsibilities at Danaher/Fluke and Saint-Gobain. In his early career, he was a strategy consultant at Bain & Company and a senior financial analyst at Intel.

Mr. He received his MBA degree from Goizueta Business School at Emory University, M.S. degree in Economics from Shanghai Univ. of Science and Technology, and bachelor degree in engineering from Zhejiang University.

公司简介：

TandemAI是一家先进的技术公司，致力于降低进入药物发现领域最先进工具的门槛。我们的集成药物发现平台结合了一套专有的人工智能和基于物理的药物发现工具、定制的超级计算基础设施和大规模湿实验室操作，使药物发现中最先进工具的访问民主化，并提升研究人员的体验。 

TandemAI的科学家协作团队与全球科学界合作，大幅提高临床前候选药物的成功率，并最终帮助改善等待新治疗方案的患者的生活。

TandemAI目前的重点是帮助客户推进临床前小分子候选药物。我们的愿景是与客户一起成长，以支持他们在生物制剂和其他大分子疗法方面的发现工作。